Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Donaldson

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Progress in Clinical and Biological Research|January 1, 1988
Estrogens and antiestrogens mediate contrasting transitions in estrogen receptor conformation which determine chromatin access: a review and synthesis of recent observationsK Nelson, J R van Nagell, H Gallion, et al.
Cancer|November 1, 1977
Small cell cancer of the uterine cervixJ R Van Nagell, E S Donaldson, E G Wood, et al.
American Journal of Obstetrics and Gynecology|October 15, 1979
Therapy of endodermal sinus tumor of the ovaryH Gallion, J R van Nagell, D F Powell, et al.
American Journal of Obstetrics and Gynecology|June 15, 1983
Immature teratoma of the ovaryH Gallion, J R van Nagell, E S Donaldson, et al.
Cell and Tissue Kinetics|March 1, 1985
Alterations in metaphase durations in cells derived from human tumoursJ E Sisken, S V Bonner, S D Grasch, et al.
Gynecologic Oncology|June 1, 1987
Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancerH H Gallion, J R van Nagell, E S Donaldson, et al.
Gynecologic Oncology|July 1, 1987
Patient-controlled analgesia in gynecologic oncologyH H Gallion, D P Wermeling, T S Foster, et al.
American Journal of Obstetrics and Gynecology|June 1, 1977
The prognostic significance of carcinoembryonic antigen in the plasma and tumors of patients with endometrial adenocarcinomaJ R van Nagell, E S Donaldson, E G Wood, et al.
Cancer|July 15, 1981
Biochemical markers in the plasma and tumors of patients with gynecologic malignanciesJ R van Nagell, E S Donaldson, M B Hanson, et al.
Clinical Pharmacy|December 1, 1986
Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophylaxis in vaginal hysterectomyR P Rapp, J E Connors, W D Hager, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Progress in Clinical and Biological Research|January 1, 1988
Estrogens and antiestrogens mediate contrasting transitions in estrogen receptor conformation which determine chromatin access: a review and synthesis of recent observationsK Nelson, J R van Nagell, H Gallion, et al.
Cancer|November 1, 1977
Small cell cancer of the uterine cervixJ R Van Nagell, E S Donaldson, E G Wood, et al.
American Journal of Obstetrics and Gynecology|October 15, 1979
Therapy of endodermal sinus tumor of the ovaryH Gallion, J R van Nagell, D F Powell, et al.
American Journal of Obstetrics and Gynecology|June 15, 1983
Immature teratoma of the ovaryH Gallion, J R van Nagell, E S Donaldson, et al.
Cell and Tissue Kinetics|March 1, 1985
Alterations in metaphase durations in cells derived from human tumoursJ E Sisken, S V Bonner, S D Grasch, et al.
Gynecologic Oncology|June 1, 1987
Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancerH H Gallion, J R van Nagell, E S Donaldson, et al.
Gynecologic Oncology|July 1, 1987
Patient-controlled analgesia in gynecologic oncologyH H Gallion, D P Wermeling, T S Foster, et al.
American Journal of Obstetrics and Gynecology|June 1, 1977
The prognostic significance of carcinoembryonic antigen in the plasma and tumors of patients with endometrial adenocarcinomaJ R van Nagell, E S Donaldson, E G Wood, et al.
Cancer|July 15, 1981
Biochemical markers in the plasma and tumors of patients with gynecologic malignanciesJ R van Nagell, E S Donaldson, M B Hanson, et al.
Clinical Pharmacy|December 1, 1986
Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophylaxis in vaginal hysterectomyR P Rapp, J E Connors, W D Hager, et al.
Pageof 8